BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

President Donald Trump issued executive orders late Friday reviving some of his first term’s anti-abortion policies, like ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, one physician said.

Haivision Systems Inc. ("Haivision" or the "Company") , a leading global provider of mission critical, real-time video networking and visual collaboration solutions, today announced that it has ...

Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert therapeutic changes into the genome, today ...

Larry Robbins is an American hedge fund manager, philanthropist, and the founder, CEO, and portfolio manager of Glenview ...